Skip to main content

Table 5 Effect of predictors and evolution of CD4 cell count on HIV infected patients on ART

From: Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam

  Bivariate   Adjusted  
Characteristics Coeff (95% CI) p-value Adj.sq.Coeff (95% CI) p-value
Intervention group 0.2 (−0.6;−0.9) 0.69   
Female gender −3.0 (−3.8;−2.3) <0.001   
Age <35 years −0.3 (−1.1;−0.6) 0.54   
Severe HIV (clinical stage 3 or 4) −2.1 (−2.8;−1.4) <0.001   
History of IDU −2.1 (−2.8;−1.4) <0.001   
ART-non-naïve status 0.8 (−0.8;2.5) 0.32   
TB history −0.2 (−1.2;0.8) 0.68   
VL at baseline ≥100,000 copies/ml −2.8 (−3.6;−2.0) <0.001 −0.9 (−1.5;−0.3) <0.01
CD4 at baseline <100 cells/μl −6.8 (−7.4;−6.3) <0.001 −5.7 (−6.3;−5.1) <0.001
Having an HIV-infected family member 2.5 (1.8;3.3) <0.001 1.3 (0.8;1.9) <0.001
From Ha long CDC OPC −0.5 (−1.2;0.3) 0.22   
History of OIs 1.1 (0.3;1.9) <0.01   
Changed ART regimen 1.0 (0.1;1.8) <0.05   
Incomplete adherence (missing more than one doses in 24 months) −1.3 (−3.1;0.5) 0.15   
Month 0.4 (0.4;0.4) <0.001 0.39 (0.38;0.41) <0.001
  1. OIs opportunistic infections, VL viral load, IDU Injecting drug use, TB tuberculosis, ART Antiretroviral therapy, OPC outpatient clinic, Coeff Coefficient, adj.sq.Coeff adjusted square Coefficient